Polyguanine sequences fold into G-quadruplex structures in the presence of
monovalent cations. It is accepted that the telomeric
DNA region consists of G-quadruplex structure. There are reports that potential G-quadruplex forming motifs are also present in the promoter region of some proto-oncogenes such as c-myc, c-kit, KRAS, etc. Small molecules with the potential to stabilize the telomeric DNA quadruplex have emerged as potential
anticancer agents. We have studied the interaction of
ellipticine, a putative
anticancer agent from a plant source, with a human telomeric DNA sequence (H24). Spectroscopic and calorimetric studies indicate that the association of
ellipticine with H24 is an entropically driven phenomenon with a 2:3 (H24:
ellipticine) stoichiometry. Though
ellipticine binding does not induce any major structural perturbation in H24, the association leads to formation of a complex with enhanced thermal stability. An assay with the
telomerase repeat amplification protocol shows that
ellipticine inhibits
telomerase activity in MDAMB-231
breast cancer cell line extracts. This is the first report of the quadruplex binding ability of
ellipticine. Using the results, we propose that along with
DNA intercalation and/or
topoisomerase II inhibition, interaction with the telomeric
DNA region and the resultant inhibition of
telomerase activity might be an additional mode of action for its anticancer property.